Huma Therapeutics, a remote patient monitoring and virtual clinical trials platform, announced the completion of its latest Series C funding round of approximately $130 million.
![ModivCare Acquires Remote Patient Monitoring Company VRI Intermediate](https://mercomcapital.com/wp-content/uploads/2021/05/Huma-Health-Raises-130-Million-for-Remote-Patient-Monitoring-.png)
Huma Therapeutics, a remote patient monitoring and virtual clinical trials platform, announced the completion of its latest Series C funding round of approximately $130 million.